Group One Trading
KRTX

Group One Trading’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Group One Trading’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,644
Closed -$837K – 8209
2023
Q4 		$837K Buy
2,644
+2,304
+678% +$448K ﹤0.01% 2630
2023
Q3 		$57.5K Sell
340
-2,789
-89% -$524K ﹤0.01% 4964
2023
Q2 		$679K Buy
3,129
+2,676
+591% +$573K ﹤0.01% 2715
2023
Q1 		$82.3K Sell
453
-1,288
-74% -$246K ﹤0.01% 4461
2022
Q4 		$342K Buy
+1,741
New +$373K ﹤0.01% 3379
2022
Q3 		– Sell
-12,655
Closed -$2.56M – 8460
2022
Q2 		$1.6M Buy
12,655
+11,584
+1,082% +$1.33M ﹤0.01% 2257
2022
Q1 		$136K Sell
1,071
-6,893
-87% -$776K ﹤0.01% 5198
2021
Q4 		$1.04M Buy
7,964
+7,398
+1,307% +$956K ﹤0.01% 3317
2021
Q3 		$69K Sell
566
-5,567
-91% -$643K ﹤0.01% 6281
2021
Q2 		$699K Sell
6,133
-100
-2% -$11.7K ﹤0.01% 3839
2021
Q1 		$749K Buy
6,233
+3,196
+105% +$362K ﹤0.01% 3563
2020
Q4 		$309K Buy
+3,037
New +$281K ﹤0.01% 3713
2020
Q3 		– Sell
-709
Closed -$60.4K – 6656
2020
Q2 		$79K Buy
709
+133
+23% +$11.6K ﹤0.01% 4079
2020
Q1 		$41K Buy
+576
New +$49.3K ﹤0.01% 3850

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Group One Trading's KRTX Position: Q1 2024 in Review

Group One Trading sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,644 shares — an estimated $837K sold.

Group One Trading first reported a position in KRTX in Q1 2020 and held it in 14 quarters. The position peaked at $1.6M in Q2 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Group One Trading reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 2,644 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $837K.
  • Group One Trading first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 14 quarters.
  • Group One Trading's Karuna Therapeutics, Inc. Common Stock position peaked at $1.6M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.